Medical care of transsexual patients

Journal of the Gay and Lesbian Medical Association

Volumn 4, Issue 4, 2000, Pages 185-194

  Oriel, K A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Estrogen; Gender identity disorder; Hormones; Testosterone; Transgender; Transsexual

Indexed keywords

ESTROGEN; HORMONE; TESTOSTERONE;

ANAMNESIS; DOCTOR PATIENT RELATION; FAMILY HISTORY; FOLLOW UP; GENDER IDENTITY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HOMOSEXUALITY; HORMONAL THERAPY; HUMAN; LABORATORY TEST; MENTAL HEALTH; PHYSICAL EXAMINATION; PRESCRIPTION; PRIMARY MEDICAL CARE; REVIEW; WELLBEING;

EID: 0034534602     PISSN: 10907173     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026563806480     Document Type: Review

References (36)

1. Transsexuals: The boundaries of sexual identity and gender
2. Multistep treatment concept of transsexual patients
3. Endocrine management of transsexual
4. Hormonal therapy of gender dysphoria: The female-to-male transsexual
5. Mortality and morbidity in transsexual patients with cross-gender hormone treatment
6. The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women
7. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females
8. Sex-related differences in hematological values. A study on the erythrocyte and granulocyte count, plasma iron, and iron-binding proteins in human transsexuals on contrasexual hormone therapy
9. Chronic anovulation syndrome and associated neoplasia
10. Ovarian morphology in long-term androgen-treated female to male transsexuals
11. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects
12. Endocrine evaluation of forty female-to-male transsexuals: Increased frequency of polycystic ovarian disease in female transsexualism
13. Polycystic ovaries are a common finding in untreated female to male transsexuals
14. Endocrine therapy of transsexualism and potential complications of long-term treatment
15. The effect of oneyear cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals
16. Transsexualism and osteoporosis
17. Cyproterone acetate and a small dose of oestrogen in the pre-operative management of male transsexuals
18. Mortality and morbidity in transsexual subjects treated with cross-sex hormones
19. Effects of estrogen treatment on sexual behavior in male-to-Female trans sexuals: Experimental and clinical observations
20. The effects of oestrogen exposure on bone mass in male to female transsexuals
21. Mammogenesis in transsexuals
22. Ischemic cerebrovascular disease and hormone therapy for infertility and transsexualism
23. Pulmonary embolism in a transsexual man taking diethylstilbestrol
24. Breast cancer in a trans-sexual man receiving hormone replacement therapy
25. Breast cancer in a male-to-female transsexual.A case report
26. Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals
27. Effect of estrogens of prolactin secretion in transsexual subjects
28. Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction
29. Hormonal therapy of gender dysphoria: The male-to-female transsexual
30. Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism
31. The effect of cyproterone acetate alone and in combination with ethinylestradiol on the hypothalamic pituitary adrenal axis, prolactin and GH release in male-to-female transsexuals
32. Mortality and morbidity in transsexual subjects treated with cross-sex hormones